Lindfors Perjohan, Unge Peter, Nyhlin Henry, Ljótsson Brjánn, Björnsson Einar S, Abrahamsson Hasse, Simrén Magnus
Department of Internal medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Scand J Gastroenterol. 2012 Apr;47(4):414-20. doi: 10.3109/00365521.2012.658858. Epub 2012 Feb 20.
OBJECTIVE: Gut-directed hypnotherapy is considered to be an effective treatment in irritable bowel syndrome (IBS) but few studies report the long-term effects. This retrospective study aims to evaluate the long-term perceived efficacy of gut-directed hypnotherapy given outside highly specialized hypnotherapy centers. METHODS: 208 patients, who all had received gut-directed hypnotherapy, were retrospectively evaluated. The Subjective Assessment Questionnaire (SAQ) was used to measure changes in IBS symptoms, and patients were classified as responders and non-responders. Patients were also asked to report changes in health-care seeking, use of drugs for IBS symptoms, use of alternative non-pharmacological treatments, and if they still actively used hypnotherapy. RESULTS: Immediately after hypnotherapy, 103 of 208 patients (49%) were responders and 75 of these (73%) had improved further at the follow-up 2-7 years after hypnotherapy (mean 4 years). A majority of the responders still used hypnotherapy on a regular basis at follow-up (73%), and the responders reported a greater reduction in health-care seeking than non-responders. A total of 87% of all patients reported that they considered gut-directed hypnotherapy to be worthwhile, and this differed between responders and non-responders (100% vs. 74%; p < 0.0001). CONCLUSION: This long-term follow-up study indicates that gut-directed hypnotherapy in refractory IBS is an effective treatment option with long-lasting effects, also when given outside highly specialized hypnotherapy centers. Apart from the clinical benefits, the reduction in health-care utilization has the potential to reduce the health-care costs.
目的:肠道导向催眠疗法被认为是治疗肠易激综合征(IBS)的一种有效方法,但很少有研究报告其长期效果。这项回顾性研究旨在评估在非高度专业化催眠治疗中心进行的肠道导向催眠疗法的长期感知疗效。 方法:对208例均接受过肠道导向催眠疗法的患者进行回顾性评估。采用主观评估问卷(SAQ)来测量IBS症状的变化,并将患者分为反应者和无反应者。还要求患者报告就医情况的变化、用于IBS症状的药物使用情况、替代非药物治疗的使用情况,以及他们是否仍在积极使用催眠疗法。 结果:催眠治疗后立即有103例(49%)患者为反应者,其中75例(73%)在催眠治疗后2至7年(平均4年)的随访中进一步改善。大多数反应者在随访时仍定期使用催眠疗法(73%),且反应者报告的就医减少情况比无反应者更明显。共有87%的患者报告他们认为肠道导向催眠疗法是值得的,反应者和无反应者之间存在差异(100%对74%;p<0.0001)。 结论:这项长期随访研究表明,难治性IBS的肠道导向催眠疗法是一种有效的治疗选择,具有持久的效果,即使是在非高度专业化催眠治疗中心进行治疗时也是如此。除了临床益处外,医疗保健利用率的降低有可能降低医疗保健成本。
Scand J Gastroenterol. 2012-4
Neurogastroenterol Motil. 2012-10-11
Heliyon. 2022-12-30
Clin Med (Lond). 2021-1
Neurogastroenterol Motil. 2019-2-27
World J Gastroenterol. 2015-10-28
World J Gastroenterol. 2014-1-14